Myriad Genetics Inc
(MYGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -54,700 | -112,000 | -69,700 | -34,600 | -20,500 |
| Depreciation Amortization | 19,400 | 69,600 | 49,700 | 36,600 | 23,700 |
| Income taxes - deferred | 100 | -30,800 | -22,000 | -10,600 | -5,900 |
| Accounts receivable | -17,500 | -10,300 | -12,800 | -18,900 | -10,500 |
| Accounts payable and accrued liabilities | 7,600 | -3,500 | -1,100 | -8,200 | -3,200 |
| Other Working Capital | -24,300 | -101,500 | -98,000 | -114,000 | -57,400 |
| Other Operating Activity | 36,200 | 82,200 | 54,900 | 53,500 | 27,300 |
| Operating Cash Flow | $-33,200 | $-106,300 | $-99,000 | $-96,200 | $-46,500 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -23,500 | -45,300 | -30,700 | -13,000 | -6,300 |
| Net Acquisitions | N/A | -57,200 | N/A | N/A | N/A |
| Purchase Of Investment | N/A | -103,200 | -98,800 | -85,500 | -52,100 |
| Sale Of Investment | 58,100 | 128,200 | 87,600 | 45,200 | 17,100 |
| Investing Cash Flow | $34,600 | $-77,500 | $-41,900 | $-53,300 | $-41,300 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 6,300 | 3,900 | 3,000 | 300 |
| Other Financing Activity | -4,900 | -14,300 | -9,800 | -5,300 | -5,100 |
| Financing Cash Flow | $-4,900 | $-8,000 | $-5,900 | $-2,300 | $-4,800 |
| Exchange Rate Effect | 200 | -600 | -1,300 | -800 | -600 |
| Beginning Cash Position | 66,400 | 258,800 | 258,800 | 258,800 | 258,800 |
| End Cash Position | 63,100 | 66,400 | 110,700 | 106,200 | 165,600 |
| Net Cash Flow | $-3,300 | $-192,400 | $-148,100 | $-152,600 | $-93,200 |
| Free Cash Flow | |||||
| Operating Cash Flow | -33,200 | -106,300 | -99,000 | -96,200 | -46,500 |
| Capital Expenditure | -23,500 | -45,300 | -30,700 | -13,000 | -6,300 |
| Free Cash Flow | -56,700 | -151,600 | -129,700 | -109,200 | -52,800 |